- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Comments from Japanese politicians suggest they're up, up and away. But expect the trial balloons to come down to earth when it comes to an extra budget.
The new Treasury secretary may be a bit rowdy for Japanese diplomats, but his skepticism about structural reform will suit them just fine.
But will he have the last laugh?